Latest close
$41.21
As of Oct 2, 2026
| Fund | Portfolio weight | Shares | Change vs prev. quarter |
|---|---|---|---|
| Southeastern Asset Management | 7.54% | 3,131,835 | TRIMMED (-22.1%) |
| Patient Capital Management | 3.67% | 2,425,558 | TRIMMED (-10.2%) |
| Davis Advisors | 0.47% | 2,394,024 | TRIMMED (-0.8%) |
Source: SEC Form 13F filings for the quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. 13F filings cover long positions only and arrive up to 45 days after quarter-end.
Data unavailable — no Form 4 transactions for this ticker were parsed in the 90 days to Oct 3, 2026.
Data unavailable — no House STOCK Act transactions for this ticker were parsed in the current window (as of Oct 3, 2026).
Chart Signals
· Monthly Uptrend — Price above its 12-month moving average
Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.
| 13F signal (2021 Q3 – 2026 Q1) | Events | Win rate | Avg return | SPY | Excess |
|---|---|---|---|---|---|
| Heavy accumulation — 3+ tracked funds increased together | 10 | 50.0% | -6.7% | +2.7% | -9.4% |
Measured from SEC 13F filings: entry at each quarter’s filing deadline (the first day the list was public), exit one quarter later, dividend-adjusted closes. Past records do not guarantee future results — see Track Record and Methodology.
Open this in the GetCoattail app →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.